N/A
N=50
High-Intensity Interval Training On Women With Polycystic Ovary Syndrome.
Polycystic Ovary Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT04942366 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcome: Primary: Serum Testosterone — 2.54; 2.54; 2.39; 2.47 nmol/L
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- High intensity interval training (Other); Strength training (Other)
- Age
- Adult · 20+ yrs
- Sex
- Female
- Sponsor
- Ziauddin University
- Primary completion
- Dec 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Serum Testosterone |
2.54; 2.54; 2.39; 2.47 | — |
| PRIMARY Body Fat Percentage |
31.59; 34.12; 29.62; 32.48 | — |
| PRIMARY Physical Activity |
3491.15; 3439.60; 3928.10; 3716.60 | — |
Summary
This RCT is aimed towards determining the effectiveness of exercises based intervention strategy involving high intensity interval training exercises in improving serum testosterone level, body fat composition and physical activity in hopes to provide a definitive exercise regime for the ever common symptoms of pcos. It will be based on the theory that exercise helps in decreasing testosterone level that in turn decrease high androgen levels in the body, exercise further decreases body fat composition (obesity is a common cause or manifestation of pcos).
Eligibility Criteria
Inclusion Criteria
- BMI:
- Overweight: 23-24.9 kg/m2.
- Obese: greater than or equal to 25 kg/m2 .
- Diagnosed and referred PCO patients to the rehabilitation unit would be selected for the study.
- Aged 18-40.
- High serum testosterone level: normal range 6-86 ng/dl.
Exclusion Criteria
- On-going pregnancy.
- Any cardiovascular complication.
- Any other endocrine disorder
- Any musculoskeletal condition that hinders in performing the exercise training protocol.
Data sourced from ClinicalTrials.gov (NCT04942366). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.